financetom
CVKD
financetom
/
Healthcare
/
CVKD
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Cadrenal Therapeutics, Inc.CVKD
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
Market Cap
27.05M
Revenue (ttm)
n/a
Net Income (ttm)
-10.65M
Shares Out
1.88M
EPS (ttm)
-8.73
PE Ratio
n/a
Forward PE
n/a
Dividend
n/a
Ex-Dividend Date
n/a
Volume
8,965
Open
14.27
Previous Close
14.27
Day's Range
14.10 - 14.59
52-Week Range
5.67 - 22.90
Beta
1.45
Analysts
Strong Buy
Price Target
32.00 (+122.38%)
Earnings Date
May 8, 2025
Description >

Cadrenal Therapeutics, Inc. operates as a clinical development biopharmaceutical company.

The company focuses on developing Tecarfarin, a novel therapy with orphan drug indication for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation.

The company was incorporated in 2022 and is headquartered in Ponte Vedra, Florida.

Copyright 2023-2025 - www.financetom.com All Rights Reserved